Sumpiao, Maribeth B.
HRN: 18-22-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2025
METRONIDAZOLE 500MG (TAB)
05/26/2025
06/01/2025
PO
500mg
TID X 7 Days
Thickly MSAF; 2nd Degree Perineal Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes